New York Times Top Stories
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
New York Times Top StoriesNew York Times Top StoriesNew York Times Top StoriesThe drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.